STOCK TITAN

P3 Health Partners Inc. - PIII STOCK NEWS

Welcome to our dedicated page for P3 Health Partners news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 Health Partners stock.

P3 Health Partners Inc. (PIII) is a patient-centered, physician-led, and population health-focused healthcare company founded by Sherif Abdou and Amir Bacchus. The company is dedicated to transforming the way healthcare is delivered, with a mission to improve patient care, restore meaning to daily operations, and reinfuse care and health back into the healthcare system.

P3 operates with a unique model that aggregates and supports existing healthcare resources within the community to build an extensive network of providers. This network works collaboratively to deliver coordinated and integrated care to patients. The overarching goal is to improve patient outcomes, reduce healthcare costs, and enhance the overall experience for both patients and providers.

The team at P3 is composed of doctors, clinicians, and various support service professionals who share a deep passion for improving healthcare delivery. Recent achievements include significant growth in their provider network and successful partnerships that further their mission of delivering high-quality, cost-effective care.

Current projects at P3 include expanding their population health management services and implementing innovative care models that leverage data and technology to better serve their patient populations. Financially, P3 Health Partners Inc. continues to show robust performance, supported by its strong operational framework and strategic partnerships.

The company remains committed to its vision of transforming healthcare by working closely with physicians and healthcare providers to bring about meaningful changes in patient care delivery.

Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) is set to present at the TD Cowen 44th Annual Health Care Conference in Boston. The management will conduct a webcast of the fireside chat, available on P3's Investor Relations Website. The presentation is scheduled for Monday, March 4, 2024, at 10:30 am Eastern Time, with a replay accessible for 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) will participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah. The company's management will host investor meetings on February 13th and 14th, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) reaffirms guidance for 2023 and announces guidance for 2024 at J.P. Morgan’s 42nd Annual Healthcare Conference. The company expects to achieve meaningful profitability in 2024, with a robust pipeline of strategic partnerships driving growth and momentum across key performance metrics. Dr. Sherif Abdou, co-founder and CEO, and Atul Kavthekar, CFO, are scheduled to present on January 10, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to present at J.P. Morgan Healthcare Conference on January 10, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.67%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) to participate in BTIG Digital Health Forum with Dr. Sherif Abdou, CEO and Co-founder, on November 20, 2023. The forum will include a panel discussion at 12:00 p.m. PT/3:00 p.m. ET. P3 is a patient-centered and physician-led population health management company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.54%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) reported a 16% YTD total revenue growth, with a strong performance across markets, re-affirming 2023 guidance and providing preliminary 2024 Full-Year Adjusted EBITDA guidance of +$20 million to +$40 million. The third-quarter 2023 financial results showed a 16% increase in total revenue to $288.4 million, with a net loss of $37.3 million and an Adjusted EBITDA loss of $22.3 million. The year-to-date 2023 financial results indicated a 16% increase in total revenue to $919.5 million, with a net loss of $117.3 million and an Adjusted EBITDA loss of $41.2 million. The company is hosting a conference call and webcast on November 8, 2023, at 4:30 PM ET.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.11%
Tags
none
Rhea-AI Summary
P3 Health Partners Inc. (NASDAQ: PIII) plans to release its financial results for third-quarter 2023 and file its Quarterly Report on Form 10-Q on November 8, 2023. The company will host an investor call and webcast at 4:30pm ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
P3 Health Partners Inc. will participate in the Lake Street Best Ideas Growth Conference in New York, NY on September 14th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.08%
Tags
conferences
-
Rhea-AI Summary
P3 Health Partners Inc. to present at Wells Fargo Healthcare Conference on September 7th, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.4%
Tags
conferences
Rhea-AI Summary
P3 Health Partners Inc. announces Q2 2023 financial results with capitated revenue of $325.6M, net loss of $27.6M, and adjusted EBITDA of $0.2M. Medical margin increases by 132.1% to $50.5M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.67%
Tags

FAQ

What is the current stock price of P3 Health Partners (PIII)?

The current stock price of P3 Health Partners (PIII) is $0.213 as of November 22, 2024.

What is the market cap of P3 Health Partners (PIII)?

The market cap of P3 Health Partners (PIII) is approximately 35.2M.

What is P3 Health Partners Inc.?

P3 Health Partners Inc. (PIII) is a patient-centered, physician-led healthcare company focused on population health management.

Who founded P3 Health Partners?

P3 Health Partners was founded by Sherif Abdou and Amir Bacchus.

What is the main mission of P3 Health Partners?

The main mission of P3 Health Partners is to transform how healthcare is delivered by improving patient care and restoring meaning to healthcare operations.

How does P3 Health Partners operate?

P3 operates by aggregating and supporting the community's existing healthcare resources to build a network of providers delivering coordinated and integrated care.

What recent achievements has P3 Health Partners made?

P3 Health Partners has achieved significant growth in their provider network and formed successful partnerships to deliver high-quality, cost-effective care.

What current projects is P3 Health Partners involved in?

P3 Health Partners is expanding their population health management services and implementing innovative care models that use data and technology.

How does P3 Health Partners aim to improve patient outcomes?

P3 aims to improve patient outcomes by delivering coordinated and integrated care through a network of committed healthcare providers.

What makes P3 Health Partners unique?

P3 Health Partners is unique due to its physician-led approach and its focus on population health management, working collaboratively with existing community resources.

How can I stay updated on P3 Health Partners' news?

You can stay updated on P3 Health Partners' news by visiting stock market websites like StockTitan or the company's official website.

What is the financial condition of P3 Health Partners?

P3 Health Partners continues to show robust performance, supported by a strong operational framework and strategic partnerships.

P3 Health Partners Inc.

Nasdaq:PIII

PIII Rankings

PIII Stock Data

35.18M
126.16M
23.2%
24.99%
0.59%
Medical Care Facilities
Services-health Services
Link
United States of America
CHICAGO